SER
Serina Therapeutics Inc
2.30$
+1.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Serina Therapeutics Inc (SER) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/09/2026 | Current report (8-K) | Serina Therapeutics, Inc. (SER): Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/26/2026 | Current report (8-K) | Serina Therapeutics, Inc. (SER): Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Statements and Exhibits | View report ↗ |
| 08/24/2026 | Capital measure | Form S-1 filed with the SEC | View document ↗ |
| 08/13/2026 | Current report (8-K) | Serina Therapeutics, Inc. (SER): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 07/23/2026 | Current report (8-K) | Serina Therapeutics, Inc. (SER): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits | View report ↗ |
| 07/22/2026 | Current report (8-K) | Serina Therapeutics, Inc. (SER): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.